Chemicals - Specialty
Build Your Comparison
Side-by-side financial analysisStock Comparison
PRM vs IOSP vs ASIX vs BCPC vs TROX
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals
Chemicals - Specialty
Chemicals
PRM vs IOSP vs ASIX vs BCPC vs TROX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals | Chemicals - Specialty | Chemicals |
| Market Cap | $5.79B | $2.13B | $615M | $5.29B | $1.28B |
| Revenue (TTM) | $706M | $1.79B | $1.55B | $1.06B | $2.92B |
| Net Income (TTM) | $-190M | $114M | $10M | $158M | $-359M |
| Gross Margin | 56.4% | 27.4% | 7.4% | 36.3% | 5.8% |
| Operating Margin | -20.5% | 8.1% | 0.7% | 21.0% | -4.8% |
| Forward P/E | 20.3x | 17.9x | 15.9x | 31.5x | — |
| Total Debt | $34M | $90M | $383M | $192M | $3.59B |
| Cash & Equiv. | $326M | $293M | $20M | $75M | $211M |
PRM vs IOSP vs ASIX vs BCPC vs TROX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 21 | Jun 26 | Return |
|---|---|---|---|
| Perimeter Solutions… (PRM) | 100 | 301.9 | +201.9% |
| Innospec Inc. (IOSP) | 100 | 106.6 | +6.6% |
| AdvanSix Inc. (ASIX) | 100 | 50.4 | -49.6% |
| Balchem Corporation (BCPC) | 100 | 104.5 | +4.5% |
| Tronox Holdings plc (TROX) | 100 | 36.5 | -63.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PRM vs IOSP vs ASIX vs BCPC vs TROX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PRM is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 195.6% 10Y total return vs BCPC's 180.9%
- 16.4% revenue growth vs TROX's -5.7%
- +164.1% vs ASIX's -4.2%
IOSP ranks third and is worth considering specifically for valuation efficiency and defensive.
- PEG 0.56 vs ASIX's 8.46
- Beta 0.70, yield 2.0%, current ratio 2.79x
- Better valuation composite
Among these 5 stocks, ASIX doesn't own a clear edge in any measured category.
BCPC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 16 yrs, beta 0.26, yield 0.5%
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- Lower volatility, beta 0.26, Low D/E 15.3%, current ratio 2.07x
- 15.0% margin vs PRM's -26.9%
TROX is the clearest fit if your priority is dividends.
- 3.8% yield, vs BCPC's 0.5%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.4% revenue growth vs TROX's -5.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 15.0% margin vs PRM's -26.9% | |
| Stability / Safety | Beta 0.26 vs TROX's 2.33, lower leverage | |
| Dividends | 3.8% yield, vs BCPC's 0.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +164.1% vs ASIX's -4.2% | |
| Efficiency (ROA) | 9.4% ROA vs TROX's -7.7%, ROIC 12.2% vs -0.3% |
PRM vs IOSP vs ASIX vs BCPC vs TROX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PRM vs IOSP vs ASIX vs BCPC vs TROX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ASIX leads in 1 of 6 categories
BCPC leads 1 • PRM leads 1 • IOSP leads 0 • TROX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — PRM and BCPC each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TROX is the larger business by revenue, generating $2.9B annually — 4.1x PRM's $706M. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to PRM's -26.9%. On growth, PRM holds the edge at +73.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $706M | $1.8B | $1.5B | $1.1B | $2.9B |
| EBITDAEarnings before interest/tax | -$102M | $187M | $93M | $267M | $166M |
| Net IncomeAfter-tax profit | -$190M | $114M | $10M | $158M | -$359M |
| Free Cash FlowCash after capex | $86M | $77M | -$22M | $182M | -$275M |
| Gross MarginGross profit ÷ Revenue | +56.4% | +27.4% | +7.4% | +36.3% | +5.8% |
| Operating MarginEBIT ÷ Revenue | -20.5% | +8.1% | +0.7% | +21.0% | -4.8% |
| Net MarginNet income ÷ Revenue | -26.9% | +6.4% | +0.7% | +15.0% | -12.3% |
| FCF MarginFCF ÷ Revenue | +12.2% | +4.3% | -1.4% | +17.2% | -9.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +73.6% | +2.8% | +7.0% | +8.1% | +3.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +22.2% | -6.9% | -167.4% | +10.6% | +7.1% |
Valuation Metrics
ASIX leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 12.7x trailing earnings, ASIX trades at a 64% valuation discount to BCPC's 34.7x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.58x vs ASIX's 6.74x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $5.8B | $2.1B | $615M | $5.3B | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $5.5B | $1.9B | $978M | $5.4B | $4.7B |
| Trailing P/EPrice ÷ TTM EPS | -25.89x | 18.54x | 12.67x | 34.75x | -2.70x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.34x | 17.93x | 15.90x | 31.52x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 0.58x | 6.74x | 2.71x | — |
| EV / EBITDAEnterprise value multiple | — | 9.39x | 6.64x | 20.50x | 16.58x |
| Price / SalesMarket cap ÷ Revenue | 8.86x | 1.20x | 0.40x | 5.10x | 0.44x |
| Price / BookPrice ÷ Book value/share | 4.66x | 1.62x | 0.76x | 4.28x | 0.88x |
| Price / FCFMarket cap ÷ FCF | 27.74x | 24.24x | 95.81x | 30.54x | — |
Profitability & Efficiency
BCPC leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BCPC delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-30 for TROX. PRM carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to TROX's 2.48x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs TROX's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -16.4% | +8.6% | +1.3% | +12.4% | -30.4% |
| ROA (TTM)Return on assets | -6.9% | +6.3% | +0.6% | +9.4% | -7.7% |
| ROICReturn on invested capital | -11.6% | +11.2% | +4.4% | +12.2% | -0.3% |
| ROCEReturn on capital employed | -8.3% | +11.0% | +5.3% | +14.8% | -0.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 9 | 2 |
| Debt / EquityFinancial leverage | 0.03x | 0.07x | 0.47x | 0.15x | 2.48x |
| Net DebtTotal debt minus cash | -$292M | -$203M | $363M | $117M | $3.4B |
| Cash & Equiv.Liquid assets | $326M | $293M | $20M | $75M | $211M |
| Total DebtShort + long-term debt | $34M | $90M | $383M | $192M | $3.6B |
| Interest CoverageEBIT ÷ Interest expense | -5.17x | — | 1.38x | 15.23x | -1.16x |
Total Returns (Dividends Reinvested)
PRM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PRM five years ago would be worth $29,558 today (with dividends reinvested), compared to $4,471 for TROX. Over the past 12 months, PRM leads with a +164.1% total return vs ASIX's -4.2%. The 3-year compound annual growth rate (CAGR) favors PRM at 78.1% vs ASIX's -11.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +28.9% | +14.7% | +34.3% | +7.2% | +90.4% |
| 1-Year ReturnPast 12 months | +164.1% | +1.4% | -4.2% | +1.3% | +42.1% |
| 3-Year ReturnCumulative with dividends | +464.8% | -7.8% | -30.0% | +24.7% | -23.6% |
| 5-Year ReturnCumulative with dividends | +195.6% | -4.2% | -12.7% | +27.7% | -55.3% |
| 10-Year ReturnCumulative with dividends | +195.6% | +105.2% | +54.4% | +180.9% | +134.4% |
| CAGR (3Y)Annualised 3-year return | +78.1% | -2.7% | -11.2% | +7.6% | -8.6% |
Risk & Volatility
Evenly matched — PRM and BCPC each lead in 1 of 2 comparable metrics.
Risk & Volatility
BCPC is the less volatile stock with a 0.26 beta — it tends to amplify market swings less than TROX's 2.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRM currently trades 98.5% from its 52-week high vs TROX's 75.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.09x | 0.70x | 0.59x | 0.26x | 2.33x |
| 52-Week HighHighest price in past year | $36.01 | $92.14 | $26.73 | $183.90 | $10.59 |
| 52-Week LowLowest price in past year | $13.05 | $65.58 | $14.10 | $139.17 | $2.86 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +94.0% | +85.3% | +89.7% | +75.8% |
| RSI (14)Momentum oscillator 0–100 | 66.7 | 71.7 | 42.7 | 59.1 | 45.9 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 176K | 269K | 171K | 2.6M |
Analyst Outlook
Evenly matched — BCPC and TROX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PRM as "Buy", IOSP as "Hold", ASIX as "Buy", BCPC as "Buy", TROX as "Buy". Consensus price targets imply 32.8% upside for IOSP (target: $115) vs -3.6% for ASIX (target: $22). For income investors, TROX offers the higher dividend yield at 3.77% vs BCPC's 0.53%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $37.00 | $115.00 | $22.00 | $175.50 | $8.33 |
| # AnalystsCovering analysts | 2 | 9 | 6 | 10 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | +2.0% | +2.8% | +0.5% | +3.8% |
| Dividend StreakConsecutive years of raises | 0 | 12 | 0 | 16 | 0 |
| Dividend / ShareAnnual DPS | — | $1.70 | $0.63 | $0.87 | $0.30 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | 0.0% | +0.3% | +2.0% | 0.0% |
ASIX leads in 1 of 6 categories (Valuation Metrics). BCPC leads in 1 (Profitability & Efficiency). 3 tied.
PRM vs IOSP vs ASIX vs BCPC vs TROX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PRM or IOSP or ASIX or BCPC or TROX a better buy right now?
For growth investors, Perimeter Solutions, S.
A. (PRM) is the stronger pick with 16. 4% revenue growth year-over-year, versus -5. 7% for Tronox Holdings plc (TROX). AdvanSix Inc. (ASIX) offers the better valuation at 12. 7x trailing P/E (15. 9x forward), making it the more compelling value choice. Analysts rate Perimeter Solutions, S. A. (PRM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PRM or IOSP or ASIX or BCPC or TROX?
On trailing P/E, AdvanSix Inc.
(ASIX) is the cheapest at 12. 7x versus Balchem Corporation at 34. 7x. On forward P/E, AdvanSix Inc. is actually cheaper at 15. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 56x versus AdvanSix Inc. 's 8. 46x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PRM or IOSP or ASIX or BCPC or TROX?
Over the past 5 years, Perimeter Solutions, S.
A. (PRM) delivered a total return of +195. 6%, compared to -55. 3% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: PRM returned +195. 6% versus ASIX's +54. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PRM or IOSP or ASIX or BCPC or TROX?
By beta (market sensitivity over 5 years), Balchem Corporation (BCPC) is the lower-risk stock at 0.
26β versus Tronox Holdings plc's 2. 33β — meaning TROX is approximately 784% more volatile than BCPC relative to the S&P 500. On balance sheet safety, Perimeter Solutions, S. A. (PRM) carries a lower debt/equity ratio of 3% versus 2% for Tronox Holdings plc — giving it more financial flexibility in a downturn.
05Which is growing faster — PRM or IOSP or ASIX or BCPC or TROX?
By revenue growth (latest reported year), Perimeter Solutions, S.
A. (PRM) is pulling ahead at 16. 4% versus -5. 7% for Tronox Holdings plc (TROX). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -32. 8% for Perimeter Solutions, S. A.. Over a 3-year CAGR, PRM leads at 21. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PRM or IOSP or ASIX or BCPC or TROX?
Balchem Corporation (BCPC) is the more profitable company, earning 14.
9% net margin versus -31. 6% for Perimeter Solutions, S. A. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus -30. 8% for PRM. At the gross margin level — before operating expenses — PRM leads at 57. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PRM or IOSP or ASIX or BCPC or TROX more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 56x versus AdvanSix Inc. 's 8. 46x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, AdvanSix Inc. (ASIX) trades at 15. 9x forward P/E versus 31. 5x for Balchem Corporation — 15. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 32. 8% to $115. 00.
08Which pays a better dividend — PRM or IOSP or ASIX or BCPC or TROX?
In this comparison, TROX (3.
8% yield), ASIX (2. 8% yield), IOSP (2. 0% yield), BCPC (0. 5% yield) pay a dividend. PRM does not pay a meaningful dividend and should not be held primarily for income.
09Is PRM or IOSP or ASIX or BCPC or TROX better for a retirement portfolio?
For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
26), 0. 5% yield, +180. 9% 10Y return). Tronox Holdings plc (TROX) carries a higher beta of 2. 33 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BCPC: +180. 9%, TROX: +134. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PRM and IOSP and ASIX and BCPC and TROX?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PRM is a small-cap high-growth stock; IOSP is a small-cap quality compounder stock; ASIX is a small-cap deep-value stock; BCPC is a small-cap quality compounder stock; TROX is a small-cap income-oriented stock. IOSP, ASIX, BCPC, TROX pay a dividend while PRM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.